ESG

Nutraville's new brain supplement CogniSurge touts a 'glycocalyx' fix. We examine the science, the sales pitch, and what consumers should know.

The Vermont ski maker's new certification signals a shift from carbon neutrality to verified climate action. Can performance and planet truly coexist?

Orla Mining reports robust Q1 output and secures a key permit in Mexico, keeping it on track for its 2026 guidance and fueling its growth pipeline.

How one California school district modernized its campuses and trained students for green jobs—all without burdening taxpayers. Here's the financial blueprint.

A landmark grant funds research into scaffold-free tissue, a revolutionary approach that could one day eliminate the need for many knee replacements.

A global partnership aims to bring Atla-cel, a next-gen CAR-T therapy with low neurotoxicity, to children with leukaemia, potentially revolutionizing treatment.

As the $525B cold chain market booms and regulations tighten, Circle Logistics is enhancing its services to offer shippers greater reliability and compliance.

Riyadh's upcoming wood exhibition is more than a trade fair; it's a strategic pillar for Saudi Arabia's multi-trillion-dollar industrial transformation.

A new once-daily pill for hypoparathyroidism begins human testing, promising to replace burdensome injections and transform patient care. Is this the future?

A novel drug combination shows promising early results for a deadly ovarian cancer, potentially expanding the benefit of immunotherapy to more patients.

A new Salt Lake City center offers a perpetual open house, with full-scale temple room replicas designed to demystify Latter-day Saint worship for all.

A landmark treaty faces opposition from neighboring First Nations, who claim it infringes on their territory and undermines reconciliation on BC's North Coast.

CHEMEON Surface Technology streamlines its executive team to a C-level structure, aiming to accelerate innovation in hexavalent chrome alternatives.

With new funding, ImageneBio advances its unique OX40 inhibitor, IMG-007, for eczema and alopecia, but faces a divided Wall Street.

With youth melanoma a growing concern, a new curriculum gives teens free, classroom-ready tools to build lifelong sun safety habits and reduce their risk.

The FDA has cleared the first 'theragnostic' sleep apnea device, integrating treatment and monitoring to usher in an era of data-driven, personalized care.

Following a controversial DoD rule allowing personal firearms on bases, a major gun rights group offers free concealed carry classes to service members.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

Backed by Maria Sharapova, new startup Amulet launches a science-first supplement aiming to optimize women's performance throughout their entire cycle.

Over 2000 leaders will gather for the FNMPC conference, focusing on Indigenous equity ownership in major projects to build generational wealth.